Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-1-13
pubmed:abstractText
1. A cloned cDNA encoding a human 5-hydroxytryptamine3 receptor type A subunit (h5-HT3R-As) was transfected into human embryonic kidney (HEK 293) cells maintained in cell culture and a stable cell line expressing a high density of the recombinant receptor was selected. 2. Membrane homogenates prepared from transfected, but not untransfected, cells exhibited a homogeneous and saturable population (Bmax = 4.49 +/- 0.46 pmol mg-1 protein) of sites that bound the radiolabelled 5-HT3 receptor antagonist, [3H]-granisetron with high affinity (pKD = 8.87 +/- 0.08). Kinetic studies (at 37 degrees C) revealed rapid association (kappa +1 4.76 +/- 0.3 x 10(8) M-1 min-1) and dissociation (kappa -1 = 0.21 +/- 0.003 min-1) of the radioligand. 3. Selective and non-selective 5-HT3 receptor ligands competed for [3H]-granisetron binding with a rank order of potency (granisetron > ondansetron > meta-chlorophenylbiguanide > 5-HT > 2-methyl-5-HT > metoclopramide > > phenylbiguanide > cocaine > (+)-tubocurarine) identical to that established for 5-HT3 receptors endogenous to the human CNS. 4. In electrophysiological recordings performed on transfected cells, voltage-clamped at a holding potential of -60 mV, locally applied 5-HT (10 microM) evoked transient inward current responses that reversed in sign at a potential of -1.0 +/- 1.1 mV. Such responses were antagonized in a reversible manner by granisetron (1 nM). 5. The construction of a stable cell line expressing a high density of recombinant human 5-HT3 receptors which display appropriate pharmacology and function will assist in the further characterization of this receptor subtype and the exploration of species differences in 5-HT3 receptor pharmacology.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-1364827, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-1407396, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-1413088, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-1533419, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-1715528, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-1718042, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-1797317, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-2076479, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-2402301, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-2472553, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-2543418, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-2809591, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-3000889, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-3839291, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-4202581, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-518835, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-6312838, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-6472484, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-6853562, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7509203, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7537814, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7539990, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7541281, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7565620, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7620711, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7683998, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7773546, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7790853, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7938165, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7969053, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7984267, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-7984286, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-8152523, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-8229003, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-8232790, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-8247158, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-841862, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-8419547, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-8436978, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-8528560, http://linkedlifedata.com/resource/pubmed/commentcorrection/8818349-8848005
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
118
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1237-45
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells.
pubmed:affiliation
Department of Pharmacology and Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee University, U.K.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't